Figure 4.
Figure 4. Hoxb4-/- BM cells have increased tolerance to 5-FU treatment. (A) In vivo repopulation of Hoxb4-/--derived and Hoxb4+/+-derived donor cells after double treatment with 5-FU (day 1 [d1] and day 5 [d5]). The 5-FU–treated cells were competed against fresh B6.SJL cells in lethally irradiated B6.SJL recipients. (B) Level of reconstitution was measured as peripheral blood cells at 17 weeks after transplantation (mean ± SD) (each bar = 16 recipient mice from 4 donors).

Hoxb4-/-BM cells have increased tolerance to 5-FU treatment. (A) In vivo repopulation of Hoxb4-/--derived and Hoxb4+/+-derived donor cells after double treatment with 5-FU (day 1 [d1] and day 5 [d5]). The 5-FU–treated cells were competed against fresh B6.SJL cells in lethally irradiated B6.SJL recipients. (B) Level of reconstitution was measured as peripheral blood cells at 17 weeks after transplantation (mean ± SD) (each bar = 16 recipient mice from 4 donors).

Close Modal

or Create an Account

Close Modal
Close Modal